Use Options For a Chance To Buy NKTR at a 57% Discount

Looking back to 145 days ago, Nektar Therapeutics (NKTR) priced a 8,500,000 share secondary stock offering at $12.75 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time and based on early trading on Monday, the stock is now 7.5% higher than the offering price..